Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 6 (June)

1. Association between cardiorespiratory fitness and prevalence of carotid atherosclerosis among men with hypertension.
   Am Heart J, 153(6): 1001-5. [Abstract] [Full-text]
2. Hypertension Intervention Nurse Telemedicine Study (HINTS): testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control.
   Am Heart J, 153(6): 918-24. [Abstract] [Full-text]
3. Effect of chronic coffee consumption on aortic stiffness and wave reflections in hypertensive patients.
   Eur J Clin Nutr, 61(6): 796-802. [Abstract] [Full-text]
4. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure.
   Eur J Clin Nutr, 61(6): 786-95. [Abstract] [Full-text]
5. Pre-pubertal induction of experimental diabetes protects against early renal macrophage infiltration.
   Pediatr Nephrol, 22(7): 1045-9. [Abstract] [Full-text]
6. Birth weight, postnatal growth, and risk for high blood pressure at 7 years of age: results from the Collaborative Perinatal Project.
   Pediatrics, 119(6): e1264-70. [Abstract] [Full-text]
7. Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans.
   J Physiol, 581: 863-72. [Abstract] [Full-text]
8. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients.
   Neurology, 68(23): 2035-8. [Abstract] [Full-text]
9. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China.
   Neurology, 68(23): 2031-4. [Abstract] [Full-text]
10. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
    Nature, 447(7145): 661-78. [Abstract] [Full-text]
11. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.
    J Clin Endocrinol Metab, 92(6): 2141-8. [Abstract] [Full-text]
12. Stress responsiveness in adult life: influence of mother's diet in late pregnancy.
    J Clin Endocrinol Metab, 92(6): 2208-10. [Abstract] [Full-text]
13. Blood pressure control in type II diabetics with diabetic retinopathy.
    Eye, 21(6): 708-11. [Abstract] [Full-text]
14. Effects of 12 mT static magnetic field on sympathetic agonist-induced hypertension in Wistar rats.
    Bioelectromagnetics, 28(5): 369-78. [Abstract] [Full-text]
15. Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy.
    J Neurol Sci, 258(1): 111-4. [Abstract] [Full-text]
16. Genetic and shared environmental factors do not confound the association between birth weight and hypertension: a study among Swedish twins.
    Circulation, 115(23): 2931-8. [Abstract] [Full-text]
17. Beneficial effects of physical exercise on hypertension and cardiovascular adverse remodeling of diet-induced obese rats.
    Nutr Metab Cardiovasc Dis, 17(5): 365-75. [Abstract] [Full-text]
18. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
    J Hypertens, 25(7): 1499-505. [Abstract] [Full-text]
19. Blood pressure control in Italy: results of recent surveys on hypertension.
    J Hypertens, 25(7): 1491-8. [Abstract] [Full-text]
20. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
    J Hypertens, 25(7): 1473-9. [Abstract] [Full-text]
21. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension.
    J Hypertens, 25(7): 1451-7. [Abstract] [Full-text]
22. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    J Hypertens, 25(7): 1443-50. [Abstract] [Full-text]
23. Assessment of the interaction of heritability of volume load and left ventricular mass: the HyperGEN offspring study.
    J Hypertens, 25(7): 1397-402. [Abstract] [Full-text]
24. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
    J Hypertens, 25(7): 1389-95. [Abstract] [Full-text]
25. Which measurement of home blood pressure should be used for clinical evaluation when multiple measurements are made?
    J Hypertens, 25(7): 1369-74. [Abstract] [Full-text]
26. High blood pressure in urban Moroccan Sahraoui women.
    J Hypertens, 25(7): 1363-8. [Abstract] [Full-text]
27. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a community-based cohort study in Taiwan.
    J Hypertens, 25(7): 1355-61. [Abstract] [Full-text]
28. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.
    J Hypertens, 25(7): 1327-36. [Abstract] [Full-text]
29. Differences in the quality of primary medical care for CVD and diabetes across the NHS: evidence from the quality and outcomes framework.
    BMC Health Serv Res, 7: 74. [Abstract] [Full-text]
30. Decreasing association between body mass index and blood pressure over time.
    Epidemiology, 18(4): 493-500. [Abstract] [Full-text]
31. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients.
    Am J Epidemiol, 166(1): 19-27. [Abstract] [Full-text]
32. Plasma corticosterone levels is elevated in rats submitted to chronic intermittent hypoxia.
    Auton Neurosci, 134(1): 115-7. [Abstract] [Full-text]
33. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    J Cardiovasc Pharmacol, 49(6): 394-400. [Abstract] [Full-text]
34. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
    J Cardiovasc Pharmacol, 49(6): 362-8. [Abstract] [Full-text]
35. Raloxifene modulates pulmonary vascular reactivity in spontaneously hypertensive rats.
    J Cardiovasc Pharmacol, 49(6): 355-61. [Abstract] [Full-text]
36. Effects of PPAR-gamma knock-down and hyperglycemia on insulin signaling in vascular smooth muscle cells from hypertensive rats.
    J Cardiovasc Pharmacol, 49(6): 346-54. [Abstract] [Full-text]
37. Randomized trial of acupuncture to lower blood pressure.
    Circulation, 115(24): 3121-9. [Abstract] [Full-text]
38. Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
    Hypertension, 50(1): 123-9. [Abstract] [Full-text]
39. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats.
    Hypertension, 50(1): 62-8. [Abstract] [Full-text]
40. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats.
    Hypertension, 50(1): 69-74. [Abstract] [Full-text]
41. Role of matrix metalloproteinases in early hypertensive vascular remodeling.
    Hypertension, 50(1): 212-8. [Abstract] [Full-text]
42. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function.
    Hypertension, 50(1): 47-53. [Abstract] [Full-text]
43. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.
    Hypertension, 50(1): 228-33. [Abstract] [Full-text]
44. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview.
    Hypertension, 50(1): 181-8. [Abstract] [Full-text]
45. Treatment of young subjects at high familial risk of future hypertension with an angiotensin-receptor blocker.
    Hypertension, 50(1): 89-95. [Abstract] [Full-text]
46. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Hypertension, 50(1): 110-5. [Abstract] [Full-text]
47. Age, hypertension and arterial function.
    Clin Exp Pharmacol Physiol, 34(7): 665-71. [Abstract] [Full-text]
48. Genetic influences on the arterial wall.
    Clin Exp Pharmacol Physiol, 34(7): 652-7. [Abstract] [Full-text]
49. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats.
    Clin Exp Pharmacol Physiol, 34(7): 617-23. [Abstract] [Full-text]
50. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Clin Exp Pharmacol Physiol, 34(7): 574-80. [Abstract] [Full-text]
51. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects.
    Am Heart J, 154(1): 79.e9-15. [Abstract] [Full-text]
52. Renovascular hypertension commencing during fetal life.
    Arch Dis Child Fetal Neonatal Ed, 92(4): F301-4. [Abstract] [Full-text]
53. Follow-up of early unilateral nephrectomy for hypertension.
    Arch Dis Child Fetal Neonatal Ed, 92(4): F305-6. [Abstract] [Full-text]
54. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Lancet, 369(9579): 2079-87. [Abstract] [Full-text]
55. Indapamide decreases plasma adiponectin concentration in patients with essential hypertension.
    Kidney Blood Press Res, 30(3): 187-94. [Abstract] [Full-text]
56. Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
    Kidney Blood Press Res, 30(3): 182-6. [Abstract] [Full-text]
57. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.
    Kidney Blood Press Res, 30(3): 129-44. [Abstract] [Full-text]
58. The role of angiotensin-converting enzyme gene insertion/deletion polymorphism for blood pressure regulation in areca nut chewers.
    Transl Res, 150(1): 58-65. [Abstract] [Full-text]
59. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Am J Kidney Dis, 50(1): 133-42. [Abstract] [Full-text]
60. Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
    Am J Kidney Dis, 50(1): 78-89, 89.e1. [Abstract] [Full-text]
61. Effects of the renin-angiotensin system genes and salt sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetes.
    Diabetes, 56(7): 1905-12. [Abstract] [Full-text]
62. Primary aldosteronism in diabetic subjects with resistant hypertension.
    Diabetes Care, 30(7): 1699-703. [Abstract] [Full-text]
63. Invited commentary: identifying women with hypertension during pregnancy--is high specificity sufficient?
    Am J Epidemiol, 166(2): 125-7; discussion 128-9. [Abstract] [Full-text]
64. Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
    Clin Exp Pharmacol Physiol, 34(8): 725-31. [Abstract] [Full-text]
65. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Clin Exp Pharmacol Physiol, 34(8): 702-7. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.